NN-2901

N/A

Report date: 2022/04/18 10:15:47

Base Information

Drug NameNN-2901
Drug Alias NameNN-2901
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionStem cell growth factor receptor inhibitors
TargetsStem cell growth factor receptor
Therapy Area/IndicationsRetinopathy of Prematurity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovelty Nobility Inc
China Registration ClassN/A

Develop Information

Active CompaniesNovelty Nobility Inc
Inactive CompaniesN/A
Active IndicationsRetinopathy of Prematurity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A